Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDGL Madrigal Pharmaceuticals, Inc.

已收盘 07-26 16:00:00 EDT

284.49

+1.03

+0.36%

盘后284.49

+0.000.00%

16:01 EDT

最高289.91	最低276.63	成交量16.78万
今开287.67	昨收283.46	日振幅4.69%
总市值60.63亿	流通市值35.60亿	总股本2,131万
成交额4,766万	换手率1.34%	流通股本1,251万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDGL","market":"US","secType":"STK","nameCN":"Madrigal Pharmaceuticals, Inc.","latestPrice":284.49,"timestamp":1722024000000,"preClose":283.46,"halted":0,"volume":167769,"hourTrading":{"tag":"盘后","latestPrice":284.49,"preClose":284.49,"latestTime":"16:01 EDT","volume":2518,"amount":716345.82,"timestamp":1722024084335},"delay":0,"floatShares":12513731,"shares":21311526,"eps":-23.212076,"marketStatus":"已收盘","marketStatusCode":5,"change":1.03,"latestTime":"07-26 16:00:00 EDT","open":287.67,"high":289.9115,"low":276.63,"amount":47655177.02946,"amplitude":0.046855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-23.212076,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"adjPreClose":283.46,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":284.39,"preClose":283.46,"latestTime":"09:07 EDT","volume":11,"amount":3136.5103,"timestamp":1721999220903},"postHourTrading":{"tag":"盘后","latestPrice":284.49,"preClose":284.49,"latestTime":"16:01 EDT","volume":2518,"amount":716345.82,"timestamp":1722024084335},"volumeRatio":0.617998,"impliedVol":0.6781,"impliedVolPercentile":0.5833},"requestUrl":"/m/hq/s/MDGL","defaultTab":"news","newsList":[{"id":"2452089304","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452089304","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452089304?lang=zh_cn&edition=full","pubTime":"2024-07-19 23:14","pubTimestamp":1721402089,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日23时14分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.27%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至23时14分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，上调目标价至385美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192314509681e928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192314509681e928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2452748444","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大涨5.06%报283.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452748444","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452748444?lang=zh_cn&edition=full","pubTime":"2024-07-18 21:46","pubTimestamp":1721310389,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日21时46分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.06%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时46分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，上调目标价至385美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718214629af92fd73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718214629af92fd73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2449046357","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449046357","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449046357?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:07","pubTimestamp":1720451229,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日23时07分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.07%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Morphic Holding, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为3356.14%、177.16%、143.17%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为121.11%、50.07%、40.77%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708230709aef87c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708230709aef87c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2444217352","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报261.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444217352","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444217352?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:41","pubTimestamp":1718890893,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时41分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.14%。截至发稿，该股报261.84美元/股，成交量2.1786万股，换手率0.10%，振幅2.85%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214133968157ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214133968157ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2441069164","title":"Madrigal Pharmaceuticals, Inc.盘中异动 急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441069164","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441069164?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:41","pubTimestamp":1717767716,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时41分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.08%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时41分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，维持目标价381美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607214157af8ca97e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607214157af8ca97e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2441171067","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441171067","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441171067?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:37","pubTimestamp":1717681063,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时37分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.02%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时37分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，维持目标价381美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213744af8c6a72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213744af8c6a72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDGL","BK4588","BK4585"],"gpt_icon":0},{"id":"2441482270","title":"BUZZ-在礼来公司的肥胖症药物显示出对肝脏疤痕的益处后，NASH 药物开发商倒下了","url":"https://stock-news.laohu8.com/highlight/detail?id=2441482270","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441482270?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:09","pubTimestamp":1717600192,"startTime":"0","endTime":"0","summary":"    6月5日 - ** NASH药物开发商Madrigal Pharmaceuticals   股价下跌约10%，报220.76美元；Akero Therapeutics   下跌3.3%，报18.58美元；89Bio   下跌约2%，报8.19美元。** 礼来  报告了其肥胖症药物的中期研究数据，该药物正在一种以前被称为NASH、现在被称为代谢功能障碍相关性脂肪性肝炎的严重脂肪肝患者中进行测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU1551013342.USD","LU1023059063.AUD","IE0009355771.USD","LU0289739699.SGD","LU1623119135.USD","LU2237443622.USD","LU2491050154.USD","LU1057294990.SGD","LU2237443382.USD","LLY","LU0689472784.USD","BK4534","LU1988902786.USD","LU2237443978.SGD","LU2491050071.SGD","GB00BDT5M118.USD","MDGL","IE0004445239.USD","LU0256863811.USD","LU2265009873.SGD","LU2468319806.SGD","LU0109391861.USD","LU0882574055.USD","LU2491049909.HKD","LU1814569148.SGD","BK4007","LU0058720904.USD","LU1280957306.USD","IE00BJT1NW94.SGD","LU0882574139.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","LU2237443549.SGD","LU1804176565.USD","IE00B1BXHZ80.USD","ETNB","LU0114720955.EUR","LU0097036916.USD","LU2264538146.SGD","LU0943347566.SGD","LU1551013425.SGD","LU0820561909.HKD","AKRO","BUZZ","LU0122379950.USD","LU0079474960.USD","IE0002141913.USD","LU0708995401.HKD","LU1712237335.SGD"],"gpt_icon":0},{"id":"2441625279","title":"Madrigal Pharmaceuticals, Inc.股价重挫13.98% 市值跌6.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441625279","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441625279?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:31","pubTimestamp":1717594317,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时31分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价快速下挫13.98%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时31分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，维持目标价381美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521315795914e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521315795914e24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","MDGL","BK4139"],"gpt_icon":0},{"id":"2435437971","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435437971","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435437971?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:39","pubTimestamp":1715611154,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时39分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.15%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下：B. Riley Securities：维持Madrigal Pharmaceuticals评级，由中性调整至中性评级, 目标价由270.00美元调整至200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223915861ecd86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223915861ecd86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2435356716","title":"Madrigal Pharmaceuticals, Inc.2024财年第一财季实现净利润-1.48亿美元，同比减少92.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435356716","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435356716?lang=zh_cn&edition=full","pubTime":"2024-05-13 00:12","pubTimestamp":1715530361,"startTime":"0","endTime":"0","summary":"3月31日，Madrigal Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-1.48亿美元，同比减少92.46%；其中营业收入为0.00美元，每股基本收益为-7.38美元。从资产负债表来看，Madrigal Pharmaceuticals, Inc.总负债2.32亿美元，其中短期债务542000.00美元，资产负债比为4.67，流动比率为9.43。机构评级：截至2024年3月31日，当前有14家机构对Madrigal Pharmaceuticals, Inc.目标价做出预测，其中目标均价为363.86美元，其中最低目标价为150.00美元，最高目标价为507.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513001251875f0129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513001251875f0129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0},{"id":"2434856096","title":"B. Riley Securities：维持Madrigal Pharmaceuticals(MDGL.US)评级，由中性调整至中性评级, 目标价由270.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434856096","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434856096?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:56","pubTimestamp":1715345804,"startTime":"0","endTime":"0","summary":"B. Riley Securities：维持Madrigal Pharmaceuticals(MDGL.US)评级，由中性调整至中性评级, 目标价由270.00美元调整至200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102056468af11e7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102056468af11e7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0},{"id":"2434770047","title":"花旗：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由389.00美元调整至382.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434770047","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434770047?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:25","pubTimestamp":1715196337,"startTime":"0","endTime":"0","summary":"花旗：维持Madrigal Pharmaceuticals(MDGL.US)评级，由买入调整至买入评级, 目标价由389.00美元调整至382.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903254187e16f56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903254187e16f56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0},{"id":"2434521772","title":"摩根大通证券公司：维持Madrigal Pharmaceuticals(MDGL.US)评级，由优于大市调整至优于大市评级, 目标价由397.00美元调整至381.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434521772","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434521772?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:05","pubTimestamp":1715191510,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Madrigal Pharmaceuticals(MDGL.US)评级，由优于大市调整至优于大市评级, 目标价由397.00美元调整至381.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902051387e13dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902051387e13dd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0},{"id":"2433572709","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433572709","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433572709?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:29","pubTimestamp":1715178590,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时29分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.03%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Effector Therapeutics Inc C/Wts 31/12/2025 、Cel-Sci Corporation涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为230.45%、61.59%、25.16%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Chemomab Therapeutics Ltd，振幅分别为60.74%、43.00%、33.42%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508222952861ebcce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508222952861ebcce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDGL","BK4588","BK4585"],"gpt_icon":0},{"id":"2433785108","title":"BUZZ-Madrigal 因最近获批上市的 NASH 药物细节 \"不足 \"而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2433785108","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433785108?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:17","pubTimestamp":1715091434,"startTime":"0","endTime":"0","summary":"** 虽然没有对 Rezdiffra 第一季度的收入做出预期，但投资者希望 \"在具体的患者人数或新处方量方面获得更多有关上市进展的信息，\"Mamtani 说。** 由于与 Rezdiffra 有关的生产和上市相关成本的时间安排，公司第一季度的运营支出几乎翻了一番，达到 1.5204 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BUZZ","MDGL","BK4588","BK4139"],"gpt_icon":0},{"id":"2433788234","title":"Madrigal 制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433788234","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433788234?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:53","pubTimestamp":1715089993,"startTime":"0","endTime":"0","summary":"   * Madrigal Pharmaceuticals Inc   报告，截至3月底的季度调整后每股亏损7.38美元，低于去年同期的每股收益4.23美元。13位分析师对该季度的平均预期是每股亏损6.28美元。华尔街预期为每股亏损 7.34 美元至 4.86 美元。* Madrigal Pharmaceuticals Inc 报告的季度每股收益为亏损 7.38 美元。* 该公司一季度亏损 1.4754 亿美元。* Madrigal Pharmaceuticals Inc 的股价本季度下跌了 11.8%，今年迄今为止上涨了 1.8%。华尔街对 Madrigal Pharmaceuticals Inc 的 12 个月目标价中位数为 390.00 美元。本摘要由 LSEG 数据于世界协调时 5 月 7 日下午 01:52 自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDGL","BK4588","BK4585"],"gpt_icon":0},{"id":"2433658788","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.33%报223.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433658788","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433658788?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:34","pubTimestamp":1715088846,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时34分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.33%。截至发稿，该股报223.01美元/股，成交量3.5187万股，换手率0.17%，振幅2.13%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nanoviricides, Inc.涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为929.65%、94.94%、32.34%，振幅较大的相关个股有Clearmind Medicine Inc.、Nanoviricides, Inc.、Heron Therapeutics, Inc.，振幅分别为21.37%、12.14%、11.97%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721340687dc9f84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721340687dc9f84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2432098319","title":"Madrigal Pharmaceuticals Inc   预计每股亏损6.28美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432098319","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432098319?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:34","pubTimestamp":1714746892,"startTime":"0","endTime":"0","summary":"   * Madrigal Pharmaceuticals Inc    将于5月7日公布截至2024年3月31日的财报，预计季度营收将保持不变。*    * LSEG分析师对Madrigal Pharmaceuticals Inc的平均预期是每股亏损6.28美元。* 华尔街对 Madrigal Pharmaceuticals Inc 的 12 个月目标价中位数为 390.00 美元，高于其上次收盘价 216.05 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL"],"gpt_icon":0},{"id":"2432905515","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432905515","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432905515?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:53","pubTimestamp":1714744428,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时53分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.30%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Vaxxinity, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为110.88%、27.98%、18.65%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Effector Therapeutics Inc C/Wts 31/12/2025 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为54.50%、30.65%、26.55%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032153497a57fbef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032153497a57fbef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","MDGL"],"gpt_icon":0},{"id":"2432863304","title":"Madrigal Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432863304","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432863304?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:53","pubTimestamp":1714589583,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时53分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.08%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.99%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1411.73%、1199.87%、264.60%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020253047925a4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020253047925a4e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","MDGL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.madrigalpharma.com","stockEarnings":[{"period":"1week","weight":0.0155},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.4662},{"period":"6month","weight":0.2544},{"period":"1year","weight":0.4079},{"period":"ytd","weight":0.2251}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司，致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命，包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.032263},{"month":2,"riseRate":0.75,"avgChangeRate":0.088162},{"month":3,"riseRate":0.25,"avgChangeRate":-0.038862},{"month":4,"riseRate":0.5,"avgChangeRate":0.008688},{"month":5,"riseRate":0.375,"avgChangeRate":0.168822},{"month":6,"riseRate":0.625,"avgChangeRate":0.024173},{"month":7,"riseRate":0.125,"avgChangeRate":-0.089289},{"month":8,"riseRate":0.625,"avgChangeRate":0.081916},{"month":9,"riseRate":0.375,"avgChangeRate":0.16708},{"month":10,"riseRate":0.625,"avgChangeRate":0.051439},{"month":11,"riseRate":0.5,"avgChangeRate":0.037474},{"month":12,"riseRate":0.5,"avgChangeRate":0.475789}],"exchange":"NASDAQ","name":"Madrigal Pharmaceuticals, Inc.","nameEN":"Madrigal Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Madrigal Pharmaceuticals, Inc.,MDGL,Madrigal Pharmaceuticals, Inc.股票,Madrigal Pharmaceuticals, Inc.股票老虎,Madrigal Pharmaceuticals, Inc.股票老虎国际,Madrigal Pharmaceuticals, Inc.行情,Madrigal Pharmaceuticals, Inc.股票行情,Madrigal Pharmaceuticals, Inc.股价,Madrigal Pharmaceuticals, Inc.股市,Madrigal Pharmaceuticals, Inc.股票价格,Madrigal Pharmaceuticals, Inc.股票交易,Madrigal Pharmaceuticals, Inc.股票购买,Madrigal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}